BioMed Research International / 2019 / Article / Tab 5 / Research Article
Analgesia during Labor and Vaginal Birth among Women with Severe Maternal Morbidity: Secondary Analysis from the WHO Multicountry Survey on Maternal and Newborn Health Table 5 Potentially life-threatening conditions (PTLC) associated with analgesia during childbirth in women with severe maternal morbidity and vaginal delivery.
PLTC With Analgesia Without Analgesia Prevalence Ratio (95%CI) 601 (%) 9187 (%) Hemorrhage Uterine Rupture 6 (1.0) 42 (0.5) 2.18 (0.9 – 5.31) Postpartum hemorrhage (PPH) 233 (38.8) 2474 (26.9) 1.44 (0.98 – 2.12) Infection Puerperal endometritis 8 (1.3) 130 (1.4) 0.94 (0.37 – 2.37) Pyelonephritis 7 (1.2) 202 (2.2) 0.53 (0.21 – 1.34) Influenza 3 (0.5) 88 (1.0) 0.52 (0.15 – 1.87) Other infections 26 (4.3) 465 (5.1) 0.85 (0.35 – 2.11) Hypertension Chronic 29 (4.8) 452 (4.9) 0.98 (0.66 – 1.46) Preeclampsia 145 (24.1) 2385 (26.0) 0.93 (0.74 – 1.71) Eclampsia 7 (1.2) 339 (3.7) 0.32 (0.13 – 0.74) Other conditions HIV 4 (0.7) 786 (8.6) 0.08 (0.03 – 0.23) Anemia 90 (15.0) 2030 (22.1) 0.68 (0.39 – 1.19) Malaria / Dengue 4 (0.7) 160 (1.7) 0.38 (0.07 – 1.96) Embolic diseases 1 (0.2) 21 (0.2) 0.73 (0.09 – 5.77) Cancer 1 (0.2) 16 (0.2) 0.96 (0.12 – 7.42) Heart disease 25 (4.2) 203 (2.2) 1.88 (1.01 – 3.52) Lung disease 17 (2.8) 149 (1.6) 1.74 (1.02 – 2.99) Renal disease 7 (1.2) 92 (1.0) 1.16 (0.47 – 2.90) Hepatic disease 10 (1.7) 198 (2.2) 0.77 (0.42 – 1.43) Coincidental disease 12 (2.0) 242 (2.6) 0.76 (0.14 – 4.03) Interventions / Management Oxytocin to PPH 197 (32.4) 2136 (23.3) 1.41 (0.93 – 2.13) Other uterotonics to PPH 32 (5.3) 293 (3.2) 1.67 (0.79 – 3.55) Magnesium Sulphate 49 (8.2) 1368 (14.9) 0.55 (0.36 – 0.84) Other anticonvulsant 21 (3.5) 345 (3.8) 0.93 (0.46 – 1.90) Antibiotics 84 (14.0) 1609 (17.5) 0.80 (0.49 – 1.30) Blood products 78 (12.6) 1471 (16.0) 0.79 (0.55 – 1.14) Laparotomy 10 (1.7) 56 (0.8) 2.73 (1.33 – 5.60) Admission to ICU 31 (5.2) 392 (4.3) 1.21 (0.58 – 2.51)